To register for this live symposium:
Not able to attend in person?
Register for the live video stream:
*This video stream is a live broadcast of the symposium and can be viewed on a laptop or tablet.
Date and Location
This activity is supported by an educational grant from Genentech.
Data have shown that the use of antiviral treatment in the early stages of influenza can decrease the duration of fever and illness symptoms and can even lessen the risk of complications associated with influenza. New drug approvals create opportunities to effectively and safely treat influenza. Pharmacists should identify patients who may have influenza or who are at a high risk and be able to manage these patients’ influenza to diminish associated complications, hospitalizations, and mortality rates.
Type of Activity:
At the completion of this activity, the participant will be able to:
- Explore the etiology, pathophysiology and patient populations at high risk for influenza-related complications
- Explain the mechanisms of action and adverse effect profiles of available and recently approved antivirals for the treatment of the influenza virus
- Identify the role of the community pharmacist in educating patients about the available and recently approved antivirals for treatment of the influenza virus
No additional fee is required to attend this CPE-accredited symposium activity; however, registration to APhA2019 is required.
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.
Continuing professional education (CPE) activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
Americans with Disabilities Act
Pharmacy Times Continuing Education™ (PTCE) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call 609-378-3701.
For questions about this live CPE activity, please contact: email@example.com
Pharmacy Times Continuing Education™
2 Clarke Drive | Cranbury, NJ 08512
P: 800.597.6372 | F: 609.228.5894
James Lewis, PharmD, FIDSA
Clinical Supervisor for Infectious Disease
Carrie Koenigsfeld, PharmD
Department of Pharmacy Practice
College of Pharmacy
Sunday, March 24, 2019
Time*: 6:00 AM – 6:30 AM (Registration & Breakfast) | 6:30 AM – 8:00 AM (Main Session)
Grand Hyatt Seattle
721 Pine Street
Seattle, WA 98101
Room: Leonesa Ballroom I, II, III
A Satellite Symposium to be conducted in conjunction with APhA2019.
||Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-19-013-L01-P. The activity is available for CE credit for March 24, 2019.
All participants who attended the live symposium need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Credit must be requested no later than May 24, 2019.
Faculty disclosures will be provided prior to the presentation.
The following contributors have no relevant financial relationships with commercial interests to disclose:
Pharmacy Times Continuing Education™
Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Olivia Mastrodonato; Marisa Fennekohl; Susan Pordon; and Brianna Winters.
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.